Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marten Trendelenburg

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Arthritis and Rheumatism|October 6, 2011
Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: comment on the article by Katsumata et alMarten Trendelenburg
Swiss Medical Weekly|August 21, 2007
Complement inhibition by anti-C5 antibodies--from bench to bedside and back againMarten Trendelenburg
Springer Seminars in Immunopathology|September 29, 2005
Antibodies against C1q in patients with systemic lupus erythematosusMarten Trendelenburg
Clinical & Translational Immunology|May 10, 2021
Autoantibodies against complement component C1q in systemic lupus erythematosusMarten Trendelenburg
Journal of Leukocyte Biology|September 16, 2016
Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophagesSophia Thanei, Marten Trendelenburg
Therapeutische Umschau. Revue Therapeutique|December 3, 2008
[Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab]Birsen Arici, Marten Trendelenburg
Frontiers in Immunology|August 22, 2022
C1q as a target molecule to treat human disease: What do mouse studies teach us?Kristina Schulz, Marten Trendelenburg
Journal of Immunology (Baltimore, Md. : 1950)|February 3, 2016
Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in MacrophagesSophia Thanei, Marten Trendelenburg
BMC Research Notes|July 23, 2013
Critical incidents in a tertiary care clinic for internal medicinePaula Scharein, Marten Trendelenburg
Therapeutische Umschau. Revue Therapeutique|June 11, 2005
[Rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)]Marten Trendelenburg, Jürg Schifferli
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Arthritis and Rheumatism|October 6, 2011
Anti-C1q antibodies as a diagnostic marker of proliferative lupus nephritis: comment on the article by Katsumata et alMarten Trendelenburg
Swiss Medical Weekly|August 21, 2007
Complement inhibition by anti-C5 antibodies--from bench to bedside and back againMarten Trendelenburg
Springer Seminars in Immunopathology|September 29, 2005
Antibodies against C1q in patients with systemic lupus erythematosusMarten Trendelenburg
Clinical & Translational Immunology|May 10, 2021
Autoantibodies against complement component C1q in systemic lupus erythematosusMarten Trendelenburg
Journal of Leukocyte Biology|September 16, 2016
Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophagesSophia Thanei, Marten Trendelenburg
Therapeutische Umschau. Revue Therapeutique|December 3, 2008
[Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab]Birsen Arici, Marten Trendelenburg
Frontiers in Immunology|August 22, 2022
C1q as a target molecule to treat human disease: What do mouse studies teach us?Kristina Schulz, Marten Trendelenburg
Journal of Immunology (Baltimore, Md. : 1950)|February 3, 2016
Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in MacrophagesSophia Thanei, Marten Trendelenburg
BMC Research Notes|July 23, 2013
Critical incidents in a tertiary care clinic for internal medicinePaula Scharein, Marten Trendelenburg
Therapeutische Umschau. Revue Therapeutique|June 11, 2005
[Rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)]Marten Trendelenburg, Jürg Schifferli
Pageof 12